TABLE III.
Demographic Profile of HSV-seronegative subjectsa
| HSV-seronegative |
|||
|---|---|---|---|
| IS | non-IS | ||
| Total subjects (n) | 22 | 55 | |
| % of all HSV-seronegative subjects | 29% | 71% | |
| Identified/enrolled in: | |||
| DNA vaccine study | 9 (36%) | 16 (64%) | |
| Transmission Study | 6 (37%) | 10 (63%) | |
| IS study | 6 (35%) | 11 (65%) | |
| ICS Validation Study | 1 (5%) | 18 (95%) | |
| median age (years) | 36 (range 22-62) | 34 (range 20-72) | |
| gender: | |||
| female | 5 (23%) | 26 (47%) | |
| male | 17 (77%) | 29 (53%) | |
| race | 21 white, 1 black | 55 white | |
| Previous/current partner with HSV: | n=16 | n=21 | |
| HSV-1 only | 3 (19%) | 3 (14%) | |
| HSV-2 only | 7 (44%) | 12 (57%) | |
| HSV-1 and HSV-2 | 6 (37%) | 6 (29%) | |
| No. of lifetime sexual partners | 8 (range 1-30) | 5 (range 1-30) | |
| CMV serology | 8/22 (36%) | 7/35 (20%) | |
a
HSV-seronegative subjects were classified as IS if they possessed HSV-specific LP and/or IFN-γ ELISPOT responses